InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: jimtash post# 17662

Wednesday, 07/10/2013 12:57:26 PM

Wednesday, July 10, 2013 12:57:26 PM

Post# of 30046
No, the demand for onko sure was about $300,000 per year.

And Radient spent $10 million per year in operations.

That is why there is no takeover or merger. nobody wants to take over THAT kind of underperformance.

Every biotech CEO says the cancer industry is worth billions per year. Every intelligent investors knows it's just hype.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.